WallStSmart
LQDA

Liquidia Technologies Inc

NASDAQ: LQDA · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC

$38.15
+1.33% today

Updated 2026-04-29

Market cap
$3.39B
P/E ratio
P/S ratio
21.42x
EPS (TTM)
$-0.80
Dividend yield
52W range
$12 – $47
Volume
1.4M

Liquidia Technologies Inc (LQDA) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item2016201720182019202020212022202320242025
Revenue$13.22M$7.26M$2.71M$8.07M$739628.00$12.85M$15.94M$17.49M$14.00M$158.32M
Revenue growth (YoY)-45.1%-62.7%+198.2%-90.8%+1637.8%+24.0%+9.7%-20.0%+1031.2%
Cost of revenue$918778.00$319759.00$121391.00$807192.00$237712.00$3.02M$2.86M$2.89M$5.88M$4.42M
Gross profit$12.30M$6.94M$2.59M$7.26M$501916.00$9.83M$13.08M$14.60M$8.12M$153.90M
Gross margin93.0%95.6%95.5%90.0%67.9%76.5%82.1%83.5%58.0%97.2%
R&D$23.32M$24.75M$28.70M$40.49M$32.22M$20.52M$19.43M$43.24M$47.84M$39.28M
SG&A$4.84M$10.21M$8.75M$13.60M$27.37M$23.11M$32.41M$44.74M$81.57M$157.18M
Operating income$-15.86M$-28.03M$-34.87M$-46.82M$-59.09M$-33.80M$-38.77M$-73.38M$-121.29M$-51.38M
Operating margin-120.0%-386.2%-1288.1%-580.1%-7989.0%-263.0%-243.3%-419.6%-866.6%-32.5%
EBITDA$-15.20M$-15.21M$-32.60M$-43.42M$-55.79M$-28.20M$-35.03M$-70.05M$-115.71M$-49.85M
EBITDA margin-115.0%-209.6%-1204.4%-537.9%-7542.8%-219.4%-219.8%-400.6%-826.7%-31.5%
EBIT$-15.85M$-16.14M$-34.15M$-46.21M$-58.90M$-33.82M$-38.68M$-72.23M$-117.91M$-51.38M
Interest expense$85865.00$13.01M$18.99M$1.37M$857998.00$762000.00$2.34M$6.27M$12.49M$24.17M
Income tax
Effective tax rate0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income$-15.93M$-29.15M$-53.14M$-47.58M$-59.76M$-34.58M$-41.02M$-78.50M$-130.39M$-68.92M
Net income growth (YoY)-83.0%-82.3%+10.4%-25.6%+42.1%-18.6%-91.4%-66.1%+47.1%
Profit margin-120.6%-401.7%-1962.9%-589.5%-8080.1%-269.0%-257.4%-448.9%-931.7%-43.5%